The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Assisted Reproduction Drug Market Research Report 2025
Synopsis
The global Assisted Reproduction Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Assisted Reproduction Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Assisted Reproduction Drug.
Report Scope
The Assisted Reproduction Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Assisted Reproduction Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Assisted Reproduction Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck Serono
Merck Sharp & Dohme
Livzon Group
Zhejiang Xianju Pharmaceutical Co., Ltd.
GenSci
Shanghai First Biochemical Pharmaceutical Co. LTD
Ipsen Pharma Biotech
Solvay Pharma
Segment by Type
Gonadotropin Releasing Hormone
Follicle-stimulating Hormone
Human Choroinic Gonadotrophin
Progestogen Hormone
Segment by Application
Down Regultion
Controlled Ovarian Hyperstimulation
Induced Ovulation
luteal Support
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Assisted Reproduction Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Assisted Reproduction Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Assisted Reproduction Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Assisted Reproduction Drug.
Report Scope
The Assisted Reproduction Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Assisted Reproduction Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Assisted Reproduction Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck Serono
Merck Sharp & Dohme
Livzon Group
Zhejiang Xianju Pharmaceutical Co., Ltd.
GenSci
Shanghai First Biochemical Pharmaceutical Co. LTD
Ipsen Pharma Biotech
Solvay Pharma
Segment by Type
Gonadotropin Releasing Hormone
Follicle-stimulating Hormone
Human Choroinic Gonadotrophin
Progestogen Hormone
Segment by Application
Down Regultion
Controlled Ovarian Hyperstimulation
Induced Ovulation
luteal Support
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Assisted Reproduction Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Assisted Reproduction Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Gonadotropin Releasing Hormone
1.2.3 Follicle-stimulating Hormone
1.2.4 Human Choroinic Gonadotrophin
1.2.5 Progestogen Hormone
1.3 Market by Application
1.3.1 Global Assisted Reproduction Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Down Regultion
1.3.3 Controlled Ovarian Hyperstimulation
1.3.4 Induced Ovulation
1.3.5 luteal Support
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Assisted Reproduction Drug Market Perspective (2019-2030)
2.2 Assisted Reproduction Drug Growth Trends by Region
2.2.1 Global Assisted Reproduction Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Assisted Reproduction Drug Historic Market Size by Region (2019-2024)
2.2.3 Assisted Reproduction Drug Forecasted Market Size by Region (2025-2030)
2.3 Assisted Reproduction Drug Market Dynamics
2.3.1 Assisted Reproduction Drug Industry Trends
2.3.2 Assisted Reproduction Drug Market Drivers
2.3.3 Assisted Reproduction Drug Market Challenges
2.3.4 Assisted Reproduction Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Assisted Reproduction Drug Players by Revenue
3.1.1 Global Top Assisted Reproduction Drug Players by Revenue (2019-2024)
3.1.2 Global Assisted Reproduction Drug Revenue Market Share by Players (2019-2024)
3.2 Global Assisted Reproduction Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Assisted Reproduction Drug Revenue
3.4 Global Assisted Reproduction Drug Market Concentration Ratio
3.4.1 Global Assisted Reproduction Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Assisted Reproduction Drug Revenue in 2023
3.5 Assisted Reproduction Drug Key Players Head office and Area Served
3.6 Key Players Assisted Reproduction Drug Product Solution and Service
3.7 Date of Enter into Assisted Reproduction Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Assisted Reproduction Drug Breakdown Data by Type
4.1 Global Assisted Reproduction Drug Historic Market Size by Type (2019-2024)
4.2 Global Assisted Reproduction Drug Forecasted Market Size by Type (2025-2030)
5 Assisted Reproduction Drug Breakdown Data by Application
5.1 Global Assisted Reproduction Drug Historic Market Size by Application (2019-2024)
5.2 Global Assisted Reproduction Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Assisted Reproduction Drug Market Size (2019-2030)
6.2 North America Assisted Reproduction Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Assisted Reproduction Drug Market Size by Country (2019-2024)
6.4 North America Assisted Reproduction Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Assisted Reproduction Drug Market Size (2019-2030)
7.2 Europe Assisted Reproduction Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Assisted Reproduction Drug Market Size by Country (2019-2024)
7.4 Europe Assisted Reproduction Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Assisted Reproduction Drug Market Size (2019-2030)
8.2 Asia-Pacific Assisted Reproduction Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Assisted Reproduction Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Assisted Reproduction Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Assisted Reproduction Drug Market Size (2019-2030)
9.2 Latin America Assisted Reproduction Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Assisted Reproduction Drug Market Size by Country (2019-2024)
9.4 Latin America Assisted Reproduction Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Assisted Reproduction Drug Market Size (2019-2030)
10.2 Middle East & Africa Assisted Reproduction Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Assisted Reproduction Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Assisted Reproduction Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck Serono
11.1.1 Merck Serono Company Detail
11.1.2 Merck Serono Business Overview
11.1.3 Merck Serono Assisted Reproduction Drug Introduction
11.1.4 Merck Serono Revenue in Assisted Reproduction Drug Business (2019-2024)
11.1.5 Merck Serono Recent Development
11.2 Merck Sharp & Dohme
11.2.1 Merck Sharp & Dohme Company Detail
11.2.2 Merck Sharp & Dohme Business Overview
11.2.3 Merck Sharp & Dohme Assisted Reproduction Drug Introduction
11.2.4 Merck Sharp & Dohme Revenue in Assisted Reproduction Drug Business (2019-2024)
11.2.5 Merck Sharp & Dohme Recent Development
11.3 Livzon Group
11.3.1 Livzon Group Company Detail
11.3.2 Livzon Group Business Overview
11.3.3 Livzon Group Assisted Reproduction Drug Introduction
11.3.4 Livzon Group Revenue in Assisted Reproduction Drug Business (2019-2024)
11.3.5 Livzon Group Recent Development
11.4 Zhejiang Xianju Pharmaceutical Co., Ltd.
11.4.1 Zhejiang Xianju Pharmaceutical Co., Ltd. Company Detail
11.4.2 Zhejiang Xianju Pharmaceutical Co., Ltd. Business Overview
11.4.3 Zhejiang Xianju Pharmaceutical Co., Ltd. Assisted Reproduction Drug Introduction
11.4.4 Zhejiang Xianju Pharmaceutical Co., Ltd. Revenue in Assisted Reproduction Drug Business (2019-2024)
11.4.5 Zhejiang Xianju Pharmaceutical Co., Ltd. Recent Development
11.5 GenSci
11.5.1 GenSci Company Detail
11.5.2 GenSci Business Overview
11.5.3 GenSci Assisted Reproduction Drug Introduction
11.5.4 GenSci Revenue in Assisted Reproduction Drug Business (2019-2024)
11.5.5 GenSci Recent Development
11.6 Shanghai First Biochemical Pharmaceutical Co. LTD
11.6.1 Shanghai First Biochemical Pharmaceutical Co. LTD Company Detail
11.6.2 Shanghai First Biochemical Pharmaceutical Co. LTD Business Overview
11.6.3 Shanghai First Biochemical Pharmaceutical Co. LTD Assisted Reproduction Drug Introduction
11.6.4 Shanghai First Biochemical Pharmaceutical Co. LTD Revenue in Assisted Reproduction Drug Business (2019-2024)
11.6.5 Shanghai First Biochemical Pharmaceutical Co. LTD Recent Development
11.7 Ipsen Pharma Biotech
11.7.1 Ipsen Pharma Biotech Company Detail
11.7.2 Ipsen Pharma Biotech Business Overview
11.7.3 Ipsen Pharma Biotech Assisted Reproduction Drug Introduction
11.7.4 Ipsen Pharma Biotech Revenue in Assisted Reproduction Drug Business (2019-2024)
11.7.5 Ipsen Pharma Biotech Recent Development
11.8 Solvay Pharma
11.8.1 Solvay Pharma Company Detail
11.8.2 Solvay Pharma Business Overview
11.8.3 Solvay Pharma Assisted Reproduction Drug Introduction
11.8.4 Solvay Pharma Revenue in Assisted Reproduction Drug Business (2019-2024)
11.8.5 Solvay Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Assisted Reproduction Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Gonadotropin Releasing Hormone
Table 3. Key Players of Follicle-stimulating Hormone
Table 4. Key Players of Human Choroinic Gonadotrophin
Table 5. Key Players of Progestogen Hormone
Table 6. Global Assisted Reproduction Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Assisted Reproduction Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Assisted Reproduction Drug Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Assisted Reproduction Drug Market Share by Region (2019-2024)
Table 10. Global Assisted Reproduction Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Assisted Reproduction Drug Market Share by Region (2025-2030)
Table 12. Assisted Reproduction Drug Market Trends
Table 13. Assisted Reproduction Drug Market Drivers
Table 14. Assisted Reproduction Drug Market Challenges
Table 15. Assisted Reproduction Drug Market Restraints
Table 16. Global Assisted Reproduction Drug Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Assisted Reproduction Drug Market Share by Players (2019-2024)
Table 18. Global Top Assisted Reproduction Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Assisted Reproduction Drug as of 2023)
Table 19. Ranking of Global Top Assisted Reproduction Drug Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Assisted Reproduction Drug Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Assisted Reproduction Drug Product Solution and Service
Table 23. Date of Enter into Assisted Reproduction Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Assisted Reproduction Drug Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Assisted Reproduction Drug Revenue Market Share by Type (2019-2024)
Table 27. Global Assisted Reproduction Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Assisted Reproduction Drug Revenue Market Share by Type (2025-2030)
Table 29. Global Assisted Reproduction Drug Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Assisted Reproduction Drug Revenue Market Share by Application (2019-2024)
Table 31. Global Assisted Reproduction Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Assisted Reproduction Drug Revenue Market Share by Application (2025-2030)
Table 33. North America Assisted Reproduction Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Assisted Reproduction Drug Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Assisted Reproduction Drug Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Assisted Reproduction Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Assisted Reproduction Drug Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Assisted Reproduction Drug Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Assisted Reproduction Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Assisted Reproduction Drug Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Assisted Reproduction Drug Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Assisted Reproduction Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Assisted Reproduction Drug Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Assisted Reproduction Drug Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Assisted Reproduction Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Assisted Reproduction Drug Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Assisted Reproduction Drug Market Size by Country (2025-2030) & (US$ Million)
Table 48. Merck Serono Company Detail
Table 49. Merck Serono Business Overview
Table 50. Merck Serono Assisted Reproduction Drug Product
Table 51. Merck Serono Revenue in Assisted Reproduction Drug Business (2019-2024) & (US$ Million)
Table 52. Merck Serono Recent Development
Table 53. Merck Sharp & Dohme Company Detail
Table 54. Merck Sharp & Dohme Business Overview
Table 55. Merck Sharp & Dohme Assisted Reproduction Drug Product
Table 56. Merck Sharp & Dohme Revenue in Assisted Reproduction Drug Business (2019-2024) & (US$ Million)
Table 57. Merck Sharp & Dohme Recent Development
Table 58. Livzon Group Company Detail
Table 59. Livzon Group Business Overview
Table 60. Livzon Group Assisted Reproduction Drug Product
Table 61. Livzon Group Revenue in Assisted Reproduction Drug Business (2019-2024) & (US$ Million)
Table 62. Livzon Group Recent Development
Table 63. Zhejiang Xianju Pharmaceutical Co., Ltd. Company Detail
Table 64. Zhejiang Xianju Pharmaceutical Co., Ltd. Business Overview
Table 65. Zhejiang Xianju Pharmaceutical Co., Ltd. Assisted Reproduction Drug Product
Table 66. Zhejiang Xianju Pharmaceutical Co., Ltd. Revenue in Assisted Reproduction Drug Business (2019-2024) & (US$ Million)
Table 67. Zhejiang Xianju Pharmaceutical Co., Ltd. Recent Development
Table 68. GenSci Company Detail
Table 69. GenSci Business Overview
Table 70. GenSci Assisted Reproduction Drug Product
Table 71. GenSci Revenue in Assisted Reproduction Drug Business (2019-2024) & (US$ Million)
Table 72. GenSci Recent Development
Table 73. Shanghai First Biochemical Pharmaceutical Co. LTD Company Detail
Table 74. Shanghai First Biochemical Pharmaceutical Co. LTD Business Overview
Table 75. Shanghai First Biochemical Pharmaceutical Co. LTD Assisted Reproduction Drug Product
Table 76. Shanghai First Biochemical Pharmaceutical Co. LTD Revenue in Assisted Reproduction Drug Business (2019-2024) & (US$ Million)
Table 77. Shanghai First Biochemical Pharmaceutical Co. LTD Recent Development
Table 78. Ipsen Pharma Biotech Company Detail
Table 79. Ipsen Pharma Biotech Business Overview
Table 80. Ipsen Pharma Biotech Assisted Reproduction Drug Product
Table 81. Ipsen Pharma Biotech Revenue in Assisted Reproduction Drug Business (2019-2024) & (US$ Million)
Table 82. Ipsen Pharma Biotech Recent Development
Table 83. Solvay Pharma Company Detail
Table 84. Solvay Pharma Business Overview
Table 85. Solvay Pharma Assisted Reproduction Drug Product
Table 86. Solvay Pharma Revenue in Assisted Reproduction Drug Business (2019-2024) & (US$ Million)
Table 87. Solvay Pharma Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Assisted Reproduction Drug Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Assisted Reproduction Drug Market Share by Type: 2023 VS 2030
Figure 3. Gonadotropin Releasing Hormone Features
Figure 4. Follicle-stimulating Hormone Features
Figure 5. Human Choroinic Gonadotrophin Features
Figure 6. Progestogen Hormone Features
Figure 7. Global Assisted Reproduction Drug Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Assisted Reproduction Drug Market Share by Application: 2023 VS 2030
Figure 9. Down Regultion Case Studies
Figure 10. Controlled Ovarian Hyperstimulation Case Studies
Figure 11. Induced Ovulation Case Studies
Figure 12. luteal Support Case Studies
Figure 13. Assisted Reproduction Drug Report Years Considered
Figure 14. Global Assisted Reproduction Drug Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Assisted Reproduction Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Assisted Reproduction Drug Market Share by Region: 2023 VS 2030
Figure 17. Global Assisted Reproduction Drug Market Share by Players in 2023
Figure 18. Global Top Assisted Reproduction Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Assisted Reproduction Drug as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Assisted Reproduction Drug Revenue in 2023
Figure 20. North America Assisted Reproduction Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Assisted Reproduction Drug Market Share by Country (2019-2030)
Figure 22. United States Assisted Reproduction Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Assisted Reproduction Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Assisted Reproduction Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Assisted Reproduction Drug Market Share by Country (2019-2030)
Figure 26. Germany Assisted Reproduction Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Assisted Reproduction Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Assisted Reproduction Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Assisted Reproduction Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Assisted Reproduction Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Assisted Reproduction Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Assisted Reproduction Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Assisted Reproduction Drug Market Share by Region (2019-2030)
Figure 34. China Assisted Reproduction Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Assisted Reproduction Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Assisted Reproduction Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Assisted Reproduction Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Assisted Reproduction Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Assisted Reproduction Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Assisted Reproduction Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Assisted Reproduction Drug Market Share by Country (2019-2030)
Figure 42. Mexico Assisted Reproduction Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Assisted Reproduction Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Assisted Reproduction Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Assisted Reproduction Drug Market Share by Country (2019-2030)
Figure 46. Turkey Assisted Reproduction Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Assisted Reproduction Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Merck Serono Revenue Growth Rate in Assisted Reproduction Drug Business (2019-2024)
Figure 49. Merck Sharp & Dohme Revenue Growth Rate in Assisted Reproduction Drug Business (2019-2024)
Figure 50. Livzon Group Revenue Growth Rate in Assisted Reproduction Drug Business (2019-2024)
Figure 51. Zhejiang Xianju Pharmaceutical Co., Ltd. Revenue Growth Rate in Assisted Reproduction Drug Business (2019-2024)
Figure 52. GenSci Revenue Growth Rate in Assisted Reproduction Drug Business (2019-2024)
Figure 53. Shanghai First Biochemical Pharmaceutical Co. LTD Revenue Growth Rate in Assisted Reproduction Drug Business (2019-2024)
Figure 54. Ipsen Pharma Biotech Revenue Growth Rate in Assisted Reproduction Drug Business (2019-2024)
Figure 55. Solvay Pharma Revenue Growth Rate in Assisted Reproduction Drug Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
